However, ATF3 suppresses esophageal SCC growth by downregulating ID1 (inhibitor of DNA binding 1), blocks the metastasis of bladder cancer by regulating gelsolin-mediated remodeling of the actin cytoskeleton and inhibits the progression of hepatocellular carcinoma cells by upregulating CYR61 expression. Here, ATF3 is linked to hepatocellular carcinoma.